The Bright Elusive Butterfly of Value in Health Technology Development; Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
The current system of health technology development is characterised by multiple misalignments. The "supply" side (innovation policy-makers, entrepreneurs, investors) and the "demand" side (health policy-makers, regulators, health technology assessment, purchasers) operate under...
Saved in:
Main Authors: | Trisha Greenhalgh (Author), Nick Fahy (Author), Sara Shaw (Author) |
---|---|
Format: | Book |
Published: |
Kerman University of Medical Sciences,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies
by: Pascale Lehoux, et al.
Published: (2017) -
The Conceptualization of Value in the Value Proposition of New Health Technologies; Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
by: Sandra C. Buttigieg, et al.
Published: (2018) -
New Health Technologies: A UK Perspective; Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
by: Nassim Parvizi, et al.
Published: (2017) -
How to improve success of technology projects in health and social care
by: Trisha Greenhalgh
Published: (2018) -
Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement; Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
by: Mireille Goetghebeur, et al.
Published: (2021)